January 30, 2017
(PhysOrg) – CRISPR has broad implications for advances in health care and agriculture and has already been used to create genetically engineered mosquitos designed to help reduce the spread of malaria. In the wake of this major breakthrough, UVA Today asked University of Virginia public policy professor Randall Lutter to explain the impact of this new technology. Now a member of the faculty at UVA’s Frank Batten School of Leadership and Public Policy, Lutter is a former deputy commissioner for policy at the Food and Drug Administration, where he had a leadership role in efforts to regulate genetically engineered animals.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.